A study in Cell Metabolism suggests that semaglutide, a drug used against diabetes and obesity, could have a direct effect on osteoarthritis. Research in mice and a small clinical trial in affected knees indicate that, in addition to reducing pain, the treatment increased cartilage thickness. This suggests a possible repair of joint tissue, an effect that appears to be independent of weight loss.
Mechanism of Action: Beyond Weight, Cellular Energy ⚡
The technical findings point to the benefit possibly lying in the action at the cartilage cellular level. Laboratory experiments indicate that semaglutide would act by enhancing energy production (mitochondrial) in chondrocytes, the cartilage cells. This energy boost would facilitate tissue repair and maintenance processes, translating into a measurable increase in its thickness. The challenge now is to confirm this mechanism in humans.
Ozempic: From Fat-Burner to Joint-Filler 😏
The pharmaceutical industry must be rubbing their hands. First they convinced us we needed their product for sugar, then for the scale, and now it turns out it also works for creaky knees. Soon they'll say it fixes the car windshield and fills wall holes. The irony is that, after years searching for a cartilage regenerator, it might be hidden in a vial that many used just to lose a few pounds. The polypharmacy of the future will be one injection for everything.